| Structure | Chemical Name | CAS | MF |
|
COCCIDIOIDESIMMUNODIFFUSIONANTIGEN,IDTP&IDCF
|
|
|
|
(-)-Coccinine
|
485-57-4
|
C17H19NO4
|
|
|
Coccidioidin
|
12622-73-0
|
|
|
|
Coccinia indica lectin
|
|
|
|
|
COCCIDIOIDESIMMITIS
|
|
|
|
|
COCCINIAGRANDIS
|
|
|
|
|
Coccidiostats
|
|
|
|
Cocculidine
|
27675-40-7
|
C18H23NO2
|
|
Cocculolidine
|
13497-04-6
|
C15H19NO3
|
|
|
Coccutrine
|
|
C18H23NO3
|
|
|
COC D-92 - NOMINAL FLASH POINT (138 )
|
|
|
|
|
COC D-92 - NOMINAL FLASH POINT (200 )
|
|
|
|
|
COC D-92 - NOMINAL FLASH POINT (230 )
|
|
|
|
|
coboglobin
|
|
|
|
|
CMV PEPTIDE MIX
|
|
|
|
|
COCE protocol
|
|
|
|
C6-(N1-methyl-1,2,3-trazolylmethylene)penem
|
102209-75-6
|
C10H9N4NaO3S
|
|
|
COCETH-7 CARBOXYLIC ACID
|
|
|
|
|
COCETH-4 GLUCOSIDE
|
|
|
|
|
COCETH-3
|
61791-13-7
|
|
|
|
COCETH-7
|
|
|
|
|
COC(GADUSMORHUA),MABANTI-:ELISA
|
|
|
|
|
CMVP regimen
|
|
|
|
|
CMV PROBE (FLUORESCEIN-CONJUGATED)
|
|
|
|
|
cob-1 protein
|
|
|
|
|
COB protocol
|
|
|
|
|
COB4 protein
|
|
|
|
COBRATEC(R) 122
|
80584-90-3
|
C24H42N4
|
|
|
COBRATEC(R) 928
|
|
|
|
|
COBRATEC(R) 911 S
|
|
|
|
|
COBRATEC(R) 939
|
|
|
|
|
COBRAVENOMFACTORANTICOMPLEMENTARYPROTEIN
|
|
|
|
Cobratec #99
|
27556-51-0
|
C6H5N3
|
|
|
COBRAVENOM
|
|
|
|
|
cobra alpha toxin, N(epsilon)-fluorescein isothiocyanate-lysine-23-
|
|
|
|
|
COBRA 1
|
|
|
|
|
Cobra Neurotoxins
|
|
|
|
|
Cobratoxin, Snake toxin from Naja naja kaouthia
|
|
|
|
|
Cobra venom anti-complementary protein from Naja naja kaouthia
|
|
|
|
|
cobra serum antitoxic protein
|
|
|
|
|
cobra toxin D
|
81603-59-0
|
|
|
|
cobra cytotoxin Vc5
|
|
|
|
|
cobra cytotoxin II
|
|
|
|
|
cobra cytotoxin III
|
115537-67-2
|
|
|
cobra cytotoxin IV
|
60488-15-5
|
C296H479N83O79S10
|
|
|
cobra protein
|
|
|
|
|
cobra venom endonuclease
|
|
|
|
|
Cobra Venoms
|
|
|
|
|
cobra cytotoxin I
|
|
|
|
COBRATEC(R) 122
|
98226-36-9
|
C24H42N4
|
|
|
COBRATEC(R) 959
|
|
|
|
|
COBRATOXIN
|
69344-74-7
|
|
|
|
COBRA VENOM FACTOR
|
|
|
|
|
Coch-5B2 protein
|
|
|
|
|
cochenillic acid
|
|
C9H6O7
|
|
|
CMV regimen
|
|
|
|
|
CochenialRed70%
|
|
|
|
|
Cochenial Red 70%
|
|
|
|
Cochinchinenin C
|
956103-79-0
|
C33H34O7
|
|
|
Cochineal (Natural red 4)
|
|
|
|
CMX 001
|
444805-28-1
|
C27H52N3O7P
|
|
|
Cochinchina MoMordica Seed Extract
|
|
|
|
|
Cochineal Red
|
|
|
|
cochinmicin I
|
143728-97-6
|
C46H47N7O12
|
|
cochinmicin IV
|
146874-41-1
|
C46H46ClN7O13
|
|
cochinmicin III
|
143728-99-8
|
C46H46ClN7O12
|
|
|
cochinolide glucopyranoside
|
|
|
|
COCHINCHINENIN
|
400603-95-4
|
C31H30O7
|
|
|
cochinolide
|
|
|
|
cochinmicin II
|
143728-98-7
|
C46H46ClN7O12
|
|
|
CMX 13
|
|
|
|
cochinmicin V
|
146925-27-1
|
C46H47N7O12
|
|
|
cochleamycin B2
|
|
|
|
|
cochleamycin A
|
|
|
|
COCHLIOQUINONE A
|
32450-25-2
|
C30H44O8
|
|
COCHLIOQUINONE B
|
32450-26-3
|
C28H40O6
|
|
|
Cochlearia officinalis, ext.
|
84961-47-7
|
|
|
Cochliodinol,fromChaetomiumglobosum.
|
11051-88-0
|
C32H30N2O4
|
|
Cochliobolic acid
|
185846-15-5
|
C25H30O6
|
|
|
COCHLEARIAOFFICINALIS
|
|
|
|
|
COCHLOSPERMUMGOSSYPIUM
|
|
|
|
|
cochleamycin A2
|
|
|
|
|
cochleamycin B
|
|
|
|
|
COCIDP-800
|
|
|
|
|
cobrotoxin b
|
|
|
|
|
Cochranes molecular model booklet
|
|
|
|
|
Cochranes atom centers for Orbit molecular models
|
|
|
|
|
Cochranes Orbit size bond tube sets
|
|
|
|
|
Cochranes Minit size bond tube sets
|
|
|
|
|
Cochranes bonded planar orbit-size carbon atom pieces
|
|
|
|
|
Cochrane molecular models Orbit, organic/inorganic, set
|
|
|
|
|
Cochranes atom centers for Minit molecular models
|
|
|
|
|
Cochranes Fieldhouse Hiliwire bonds
|
|
|
|
|
Cochranes molecular model wordcards
|
|
|
|
|
CMV/Rubella/Tox/HSV-1/HSV-2 IgM Casset
|
|
|
|
|
CMV/Rubella/Toxo/HSV-1/HSV-2 IgG Casset
|
|
|
|
|
COCILLANA BARK
|
|
|
|
|
CMV (STRAIN AD 169)
|
|
|
|
|
CMV (STRAIN TOWNE)
|
|
|
|
|
Cockayne syndrome group A protein
|
|
|